Real-time Engagement for Learning to Effectively Control Type 2 Diabetes

Launched by UNIVERSITY OF PITTSBURGH · Apr 16, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how using a smartphone app that provides real-time information about blood sugar levels and health habits can help young people manage their type 2 diabetes (T2D) better. The study will last about six months, starting with a short period to get everyone ready, followed by a 90-day phase where participants will receive prompts to check their blood sugar and health data. This will be tracked using a Continuous Glucose Monitor (CGM) and a Fitbit activity tracker. After this active phase, there will be another 90 days to see how well participants continue to use the app and engage with their health data.

To join this study, participants should be aged between 18 and 30, have a diagnosis of type 2 diabetes, and have certain blood sugar levels. They should also be comfortable using English since the app is in English. However, those who are pregnant, have certain medical conditions, or who have had eating disorders won't be able to participate. Throughout the study, participants can expect support in learning how to manage their diabetes more effectively while receiving guidance based on their own health data.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • type 2 diabetes: negative diabetes autoantibodies, no suspicion for monogenic diabetes
• • HbA1c ≥7.0%, stable medication use (≥3 months)
• • HbA1c 6.0-6.9% without short-acting insulin, any other stable diabetes medication use (≥3 months)
• • English-speaking (app in English)
• Exclusion Criteria:
• • Current pregnancy
• • Hydroxyurea use (CGM sensor inaccuracies)
• • Cognitive impairment or severe psychiatric condition that could interfere with participation in behavioral intervention for diabetes self-management
• • Current or previously diagnosed eating disorder